Do CD4⁺CD25⁺ immunoregulatory T cells hinder tumor immunotherapy?ANTONY, Paul Andrew; RESTIFO, Nicholas P.Journal of immunotherapy (1997). 2002, Vol 25, Num 3, pp 202-206, issn 1524-9557Article

Cellular Constituents of Immune Escape within the Tumor MicroenvironmentKERKAR, Sid P; RESTIFO, Nicholas P.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 13, pp 3125-3130, issn 0008-5472, 6 p.Article

Sorting Through Subsets: Which T-Cell Populations Mediate Highly Effective Adoptive Immunotherapy?KLEBANOFF, Christopher A; GATTINONI, Luca; RESTIFO, Nicholas P et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 9, pp 651-660, issn 1524-9557, 10 p.Article

CD4⁺CD25⁺ T regulatory cells, immunotherapy of cancer, and interleukin-2ANTONY, Paul Andrew; RESTIFO, Nicholas P.Journal of immunotherapy (1997). 2005, Vol 28, Num 2, pp 120-128, issn 1524-9557, 9 p.Article

Wnt/β-Catenin Signaling in T-Cell Immunity and Cancer ImmunotherapyGATTINONI, Luca; YUN JI; RESTIFO, Nicholas P et al.Clinical cancer research (Print). 2010, Vol 16, Num 19, pp 4695-4701, issn 1078-0432, 7 p.Article

Type I Interferons are essential for the efficacy of replicase-based DNA vaccinesLEITNER, Wolfgang W; BERGMANN-LEITNER, Elke S; HWANG, Leroy N et al.Vaccine. 2006, Vol 24, Num 24, pp 5110-5118, issn 0264-410X, 9 p.Article

CD8⁺ T-cell memory in tumor immunology and immunotherapyKLEBANOFF, Christopher A; GATTINONI, Luca; RESTIFO, Nicholas P et al.Immunological reviews. 2006, Vol 211, pp 214-224, issn 0105-2896, 11 p.Article

The in vivo expansion rate of properly stimulated transferred CD8⁺ T cells exceeds that of an aggressively growing mouse tumorHWANG, Leroy N; ZHIYA YU; PALMER, Douglas C et al.Cancer research (Baltimore). 2006, Vol 66, Num 2, pp 1132-1138, issn 0008-5472, 7 p.Article

Glucocorticoids do not inhibit antitumor activity of activated CDB⁺ T CellsHINRICHS, Christian S; PALMER, Douglas C; ROSENBERG, Steven A et al.Journal of immunotherapy (1997). 2005, Vol 28, Num 6, pp 517-524, issn 1524-9557, 8 p.Article

Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD 19 can eradicate lymphoma and normal B cellsKOCHENDERFER, James N; ZHIYA YU; FRASHERI, Dorina et al.Blood. 2010, Vol 116, Num 19, pp 3875-3886, issn 0006-4971, 12 p.Article

T-Cell Receptor Gene Therapy of Established Tumors in a Murine Melanoma ModelABAD, John D; WRZENSINSKI, Claudia; HAANEN, John B. A. G et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 1, pp 1-6, issn 1524-9557, 6 p.Article

Bcl-2 overexpression enhances tumor-specific T-cell survivalCHARO, Jehad; FINKELSTEIN, Steven E; GREWAL, Navrose et al.Cancer research (Baltimore). 2005, Vol 65, Num 5, pp 2001-2008, issn 0008-5472, 8 p.Article

Determinants of Successful CD8⁺ T-Cell Adoptive Immunotherapy for Large Established Tumors in MiceKLEBANOFF, Christopher A; GATTINONI, Luca; ROSENBERG, Steven A et al.Clinical cancer research (Print). 2011, Vol 17, Num 16, pp 5343-5352, issn 1078-0432, 10 p.Article

Therapeutic cancer vaccines: are we there yet?KLEBANOFF, Christopher A; ACQUAVELLA, Nicolas; ZHIYA YU et al.Immunological reviews. 2011, Vol 239, pp 27-44, issn 0105-2896, 18 p.Article

Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of CancerSHRIMALI, Rajeev K; ZHIYA YU; THEORET, Marc R et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 15, pp 6171-6180, issn 0008-5472, 10 p.Article

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenJOHNSON, Laura A; MORGAN, Richard A; LEE, Chyi-Chia R et al.Blood. 2009, Vol 114, Num 3, pp 535-546, issn 0006-4971, 12 p.Article

Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen. CommentaryZECHER, Daniel; LAKKIS, Fadi G; CLAVIEN, Pierre-Alain et al.Blood. 2008, Vol 111, Num 9, issn 0006-4971, 4426-4427, 4588-4595 [10 p.]Article

Agonist anti-gitr antibody enhances vaccine-induced CD8⁺ T-cell responses and tumor immunityCOHEN, Adam D; DIAB, Adi; SAKAGUCHI, Shimon et al.Cancer research (Baltimore). 2006, Vol 66, Num 9, pp 4904-4912, issn 0008-5472, 9 p.Article

CTLA-4 dysregulation of self/tumor-reactive CD8⁺ T-cell function is CD4⁺ T-cell dependentGATTINONI, Luca; RANGANATHAN, Anju; SURMAN, Deborah R et al.Blood. 2006, Vol 108, Num 12, pp 3818-3823, issn 0006-4971, 6 p.Article

In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cellsSHICHENG YANG; LUCA, Gattinoni; FANG LIU et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 5, pp 739-749, issn 0340-7004, 11 p.Article

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1ROBBINS, Paul F; MORGAN, Richard A; KAMMULA, Udai S et al.Journal of clinical oncology. 2011, Vol 29, Num 7, pp 917-924, issn 0732-183X, 8 p.Article

Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T CellsWRZESINSKI, Claudia; PAULOS, Chrystal M; KAISER, Andrew et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 1, pp 1-7, issn 1524-9557, 7 p.Article

CD8+ Enriched Young Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic MelanomaDUDLEY, Mark E; GROSS, Colin A; RESTIFO, Nicholas P et al.Clinical cancer research (Print). 2010, Vol 16, Num 24, pp 6122-6131, issn 1078-0432, 10 p.Article

High-avidity Autoreactive CD4⁺ T Cells Induce Host CTL, Overcome T_regs and Mediate Tumor DestructionBRANDMAIER, Andrew G; LEITNER, Wolfgang W; HA, Sung P et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 7, pp 677-688, issn 1524-9557, 12 p.Article

Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via notch signalingYANGBING ZHAO; PARKHURST, Maria R; ZHILI ZHENG et al.Cancer research (Baltimore). 2007, Vol 67, Num 6, pp 2425-2429, issn 0008-5472, 5 p.Article